Guardant Health Inc (NAS:GH)
$ 29.54 0 (0%) Market Cap: 3.61 Bil Enterprise Value: 3.83 Bil PE Ratio: 0 PB Ratio: 52.66 GF Score: 70/100

Guardant Health Inc at Goldman Sachs Global Healthcare Conference Transcript

Jun 14, 2022 / 04:20PM GMT
Release Date Price: $36.6 (+2.01%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Good morning, everyone. Thanks for joining us. I'm Matt Sykes, the Life Sciences Tools and Diagnostics Analyst at Goldman Sachs. And this morning, we have the pleasure of welcoming senior management from Guardant Health, Helmy Eltoukhy and AmirAli Talasaz, the Co-Chief Executive Officers; and Michael Bell, the Chief Financial Officer.

Gentlemen, welcome. Thank you for joining us today.

Questions & Answers

Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Maybe we could start out by just by having you set the stage for some key highlights in the first half of the year and maybe what investors should be focused on for the balance of '22?

Helmy Eltoukhy
Guardant Health, Inc. - Co-Founder, Co-CEO & Chairman

Yes. Thank you for having us here. It's always great to be in this wonderful venue. This has been really, I would say, instrumental and pivotal year for us in terms of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot